Research AnalistTargED BiopharmaceuticalsUtrecht, Utrecht, Netherlands
PB0855 - TGD001, a VWF-targeted thrombolytic, is safe and effective in animal models for the treatment of thrombotic thrombocytopenic purpura
Monday, June 24, 202413:45 – 14:45 ICT
